White paper on best practices for translational research in neuroendocrine neoplasms.
📅 Published: October 1, 2025
👤 Cros Jerome, Casanovas Oriol, Castaño Justo P et al.
📖 Journal of neuroendocrinology
AI-Generated Summary
Basic and translational investigations play a crucial role in advancing our understanding of neuroendocrine neoplasms (NENs). We also provide insights on how to properly handle tissue samples (particularly when starting material is limited) and discuss technical hints of relevance when planning liquid biopsy or tumor immunology studies.
⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.
Key Findings
1In this white paper by the Basic and Translational Research Group of the European Neuroendocrine Tumor Society, we discuss the qualities and drawbacks of current disease models and propose good practices for integrating advanced technologies including bulk and single-cell genomics, transcriptomics, and proteomics in contemporary NEN research.
2We also provide insights on how to properly handle tissue samples (particularly when starting material is limited) and discuss technical hints of relevance when planning liquid biopsy or tumor immunology studies.
3Future translational studies of NENs will benefit from centralized biologic material biobanking, research design planning in the context of multi-expertise committees, as well as experimental protocol optimization and sharing across the NEN scientific community.
Why It Matters
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: